A detailed history of Cromwell Holdings LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cromwell Holdings LLC holds 18 shares of IONS stock, worth $741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Holding current value
$741
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025

BUY
$25.51 - $40.0 $459 - $720
18 New
18 $0

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.85B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Cromwell Holdings LLC Portfolio

Follow Cromwell Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cromwell Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cromwell Holdings LLC with notifications on news.